RecallDepth
Class III Ongoing

Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.

This recall is currently active, issued December 24, 2025. It was issued by Somerset Therapeutics Llc.

Company
Somerset Therapeutics Llc
Recall Initiated
November 26, 2025
Posted
December 24, 2025
Recall Number
D-0237-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
28,660 20mL vials
Firm Location
Somerset, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent product:out of specification assay results observed during long term stability testing.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: A250020, Exp Date 06/30/2026

More recalls by Somerset Therapeutics Llc

View all recalls by this company →

Other recent Class III Drug recalls